THE BRITISH-SOCIETY-FOR-HEMATOLOGY GUIDELINES ON THE USE AND MONITORING OF HEPARIN 1992 - 2ND REVISION

被引:29
作者
COLVIN, BT
BARROWCLIFFE, TW
机构
关键词
D O I
10.1136/jcp.46.2.97
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:97 / 103
页数:7
相关论文
共 40 条
[1]  
ALBADA J, 1989, HEPARIN, P417
[2]  
[Anonymous], 1975, LANCET, V2, P45
[3]  
BARROWCLIFFE TW, 1988, THROMB HAEMOSTASIS, V60, P1
[4]   AN OBJECTIVE STUDY OF ALTERNATIVE METHODS OF HEPARIN ADMINISTRATION [J].
BENTLEY, PG ;
KAKKAR, VV ;
SCULLY, MF ;
MACGREGOR, IR ;
WEBB, P ;
CHAN, P ;
JONES, N .
THROMBOSIS RESEARCH, 1980, 18 (1-2) :177-187
[5]  
BONEU B, 1990, ANTITHROMBIN THERAPY, P531
[6]   REDUCTION IN FATAL PULMONARY-EMBOLISM AND VENOUS THROMBOSIS BY PERIOPERATIVE ADMINISTRATION OF SUBCUTANEOUS HEPARIN - OVERVIEW OF RESULTS OF RANDOMIZED TRIALS IN GENERAL, ORTHOPEDIC, AND UROLOGIC SURGERY [J].
COLLINS, R ;
SCRIMGEOUR, A ;
YUSUF, S ;
PETO, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1162-1173
[7]   OSTEOPENIA IN PREGNANCY DURING LONG-TERM HEPARIN TREATMENT - A RADIOLOGICAL STUDY POST PARTUM [J].
DAHLMAN, T ;
LINDVALL, N ;
HELLGREN, M .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (03) :221-228
[8]  
DESWIET M, 1983, BRIT J OBSTET GYNAEC, V90, P1129
[9]  
GALLUS A, 1986, LANCET, V2, P1293
[10]   BIOAVAILABILITY AND ANTAGONIZATION OF THE LOW-MOLECULAR-WEIGHT HEPARIN CY-216 IN MAN [J].
HARENBERG, J ;
WURZNER, B ;
ZIMMERMANN, R ;
SCHETTLER, G .
THROMBOSIS RESEARCH, 1986, 44 (04) :549-554